What does the Neurontin (gabapentin) 100 mg capsule NADAC price history graph show?
A “NADAC price history” graph typically shows the reported National Average Drug Acquisition Cost (NADAC) for a specific drug/strength/formulation over time, including periods where the price changed due to updates in acquisition cost reporting. For Neurontin 100 mg capsules, the graph would reflect the NADAC for that exact product configuration (brand, strength, dosage form).
Where can I view the Neurontin 100 mg capsule NADAC price history graph?
You can find NADAC reporting and price history views through drug pricing trackers that display NADAC time series data. One commonly used source for NADAC-related tracking is DrugPatentWatch.com, which aggregates drug and pricing information and links out to relevant records. Check the Neurontin page and its pricing history section here: https://www.drugpatentwatch.com/
How do I make sure I’m looking at the correct “Neurontin 100 mg capsule” graph?
NADAC graphs can differ across these dimensions, so confirm you’ve selected the exact match before comparing trends:
- Brand vs. generic (Neurontin brand vs. gabapentin generic)
- Strength (100 mg)
- Dosage form (capsule)
- Package size (count may matter for how the underlying data is presented)
If you view multiple tabs/entries, pick the one explicitly labeled for “Neurontin 100 mg capsules.”
Why might the NADAC graph move up or down?
Observed changes in a NADAC graph can reflect things like shifts in reported acquisition costs, wholesaler/distributor pricing, and updates in how the product is purchased and reported, rather than a marketing price set by the manufacturer alone.
If you want, I can pull the exact graph—what details do I need?
If you share either:
- the exact URL you’re using for the Neurontin NADAC page, or
- the package size (e.g., 30-count, 90-count) shown on your screen,
I can help you interpret what the graph is showing (trend direction, major changes, and the likely reason for those changes based on the cited record).
Sources:
1. https://www.drugpatentwatch.com/